Objective:
To present the 48-month results of pegcetacoplan treatment for geographic atrophy (GA) and discuss its implications for early intervention.
Key Findings:
- Approximately 1.5 disc areas of tissue were preserved in the monthly treatment arm.
- There was a 10% to 15% further reduction in GA growth in the second two years compared to the first two years.
- Patients who crossed over from sham treatment had significantly less tissue preserved compared to those on four years of treatment.
- A one-third risk reduction of progression to absolute scotoma was observed in critical central loci on microperimetry.
Interpretation:
The findings suggest that longer duration of pegcetacoplan treatment leads to better preservation of retinal tissue and functional benefits, indicating the importance of early intervention.
Limitations:
- The study primarily focused on specific patient populations and may not generalize to all GA patients.
- Long-term safety data is still being established in real-world settings.
Conclusion:
The long-term data supports the efficacy of pegcetacoplan in preserving retinal tissue and suggests that earlier treatment could enhance patient outcomes.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
